Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Sign in
Join now
Stephanie Watson OAM, BSc, MBBS, FRANZCO, PhD, GAICD, FARVO
Stephanie Watson OAM, BSc, MBBS, FRANZCO, PhD, GAICD, FARVO Advisory Board
Myron Yanoff MD
Myron Yanoff MD Editor-in-Chief
Joseph Sassani MD
Joseph W. Sassani MD Associate Editor
See All Experts
featured
Published in Eye Care

Expert Opinion / Interview · October 13, 2022

Patients With Neovascular AMD: Outcomes of Switching Eyes That Were Stable on Aflibercept to Ranibizumab vs Continuing Aflibercept

Esther Bowie MD
Interview with
Esther M. Bowie MD

 

 Save  Recommend
 Share

Further Reading

Related Videos